Malaria remains a public health problem in Cameroon and antimalarial drug resistance
hampers proper control of the disease. Several studies have been carried out on …

The emergence of resistance to antimalarials has prompted the steady switch to novel
therapies for decades. Withdrawal of antimalarials, such as chloroquine in sub-Saharan …

Malaria morbidity and mortality continue to increase across sub-Saharan Africa. This is
largely as a result of the continued use of chloroquine and sulfadoxine-pyrimethamine …

Introduction Antimalarial drugs including artemisinin-based combination therapy (ACT)
regimens and sulphadoxine-pyrimethamine (SP) are used in Ghana for malaria therapeutics …

Background Plasmodium falciparum drug resistance surveillance is key to successful
disease control and eradication. Contemporary methods that only allow determination of …

Background The emergence of parasite drug resistance, especially Plasmodium falciparum,
persists as a major obstacle for malaria control and elimination. To develop effective public …

Abstract Context The Democratic Republic of Congo (DRC), one of the most malaria-
affected countries worldwide, is a potential hub for global drug-resistant malaria. This study …

Drug-resistant malaria parasites pose a threat to global malaria control efforts, and it is
important to know the extent of these drug-resistant mutations in each region to determine …

Malaria molecular surveillance remains critical in detecting and tracking emerging parasite
resistance to anti-malarial drugs. The current study employed molecular techniques to …

Population genetic diversity of Plasmodium falciparum antigenic loci is high despite large
bottlenecks in population size during the parasite life cycle. The prevalence of genetically …